Potassium

CHICAGO — A potassium binder helped patients with HF who have or are at high risk for hyperkalemia stay on spironolactone at an optimal dose, but showed a signal of HF hospitalization risk, researchers reported.

Long-term use of the potassium binder patiromer may improve clinical outcomes among patients with chronic kidney disease and hyperkalemia, according to a study.

Treating patients with chronic kidney disease and hyperkalemia with patiromer reduced serum phosphorus and serum potassium levels during a 2-week period, according to data published in the American Journal of Kidney Diseases.

ORLANDO — Using a real-time potassium monitoring device in patients on hemodialysis saves more money than the usual care and increases quality of life, according to a presenter at ASN Kidney Week.

Among patients with advanced chronic kidney disease, increasing dietary potassium consumption to recommended levels can increase blood potassium concentration on a short-term basis, according to results of this study.

Healio and Cardiology Today have aggregated a list of the most-read cardiology news of July 2022.

In women with a high-sodium diet, every 1 g increase in daily potassium intake was associated with a 2.4 mm Hg lower systolic BP, according to data from a large cohort study.

According to this study, increasing dietary potassium intake among patients with stage 3 to 4 chronic kidney disease to the recommended levels with potassium chloride supplementation increases plasma potassium on a short-term basis.

WASHINGTON — Patiromer, a novel potassium binder, was associated with a reduction in hyperkalemia in patients with HF with reduced ejection fraction, enabling an increase in adherence to optimal medical therapy, researchers reported.

Two servings of avocado per week, compared with not eating any avocado, was associated with lower risk for CVD and CHD, but not stroke, researchers reported.